Ningxia Eppen Biotech Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 3,798

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 4

  • Investments
  • 1

Ningxia Eppen Biotech General Information

Description

Provider of bio-amino acid products designed for food nutrition, animal and plant farming. The company's main products include amino acids, monosodium glutamate, corn by-products, compound fertilizer and other agricultural chemicals, enabling agriculture and food industry users to realize sustainable and eco-friendly growth.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Corporate Office
  • Yanghe Industry Park
  • Yongning
  • Yinchuan, Ningxia 750100
  • China
+86 0951
Primary Industry
Agricultural Chemicals
Parent Company
Vertical(s)
Corporate Office
  • Yanghe Industry Park
  • Yongning
  • Yinchuan, Ningxia 750100
  • China
+86 0951

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ningxia Eppen Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ningxia Eppen Biotech‘s full profile, request access.

Request a free trial

Ningxia Eppen Biotech Patents

Ningxia Eppen Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026145083-A1 Use of ncgl0762 protein and mutant thereof in production of l-isoleucine Pending 31-Dec-2024
WO-2026138946-A1 Promoter ep10 and use thereof in preparation of l-lysine Pending 27-Dec-2024
WO-2026138947-A1 Promoter ep11, and related biomaterial and use thereof Pending 27-Dec-2024
WO-2026021181-A1 Promoter, and related biological material thereof and use thereof Pending 24-Jul-2024
WO-2025252103-A1 Use of pncgl1855 (a244c) promoter and biomaterial related thereto in preparation of l-lysine Pending 06-Jun-2024 C07K14/34
To view Ningxia Eppen Biotech’s complete patent history, request access »

Ningxia Eppen Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ningxia Eppen Biotech Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ningxia Eppen Biotech‘s full profile, request access.

Request a free trial

Ningxia Eppen Biotech Investments (1)

Ningxia Eppen Biotech’s most recent deal was a Joint Venture with Joint Venture (Agritek Bio, Tatneft and Ningxia Eppen Biotech). The deal was made on 31-Oct-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Joint Venture (Agritek Bio, Tatneft and Ningxia Eppen Biotech) 31-Oct-2025 Joint Venture Agricultural Chemicals
To view Ningxia Eppen Biotech’s complete investments history, request access »

Ningxia Eppen Biotech FAQs

  • When was Ningxia Eppen Biotech founded?

    Ningxia Eppen Biotech was founded in 1999.

  • Where is Ningxia Eppen Biotech headquartered?

    Ningxia Eppen Biotech is headquartered in Yinchuan, China.

  • What is the size of Ningxia Eppen Biotech?

    Ningxia Eppen Biotech has 3,798 total employees.

  • What industry is Ningxia Eppen Biotech in?

    Ningxia Eppen Biotech’s primary industry is Agricultural Chemicals.

  • Is Ningxia Eppen Biotech a private or public company?

    Ningxia Eppen Biotech is a Private company.

  • What is the current valuation of Ningxia Eppen Biotech?

    The current valuation of Ningxia Eppen Biotech is .

  • What is Ningxia Eppen Biotech’s current revenue?

    The current revenue for Ningxia Eppen Biotech is .

  • How much funding has Ningxia Eppen Biotech raised over time?

    Ningxia Eppen Biotech has raised $34M.

  • Who are Ningxia Eppen Biotech’s investors?

    Hosen Capital and Midea Venture have invested in Ningxia Eppen Biotech.

  • When was Ningxia Eppen Biotech acquired?

    Ningxia Eppen Biotech was acquired on 23-Nov-2022.

  • Who acquired Ningxia Eppen Biotech?

    Ningxia Eppen Biotech was acquired by Star Lake Bioscience Company.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process